 Susana Arrigain
Concepts (363)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 31 | 2023 | 486 | 2.840 |
Why?
| | Glomerular Filtration Rate | 22 | 2023 | 605 | 0.950 |
Why?
| | Lung Transplantation | 8 | 2023 | 241 | 0.880 |
Why?
| | Kidney Transplantation | 8 | 2023 | 537 | 0.830 |
Why?
| | Registries | 23 | 2021 | 1762 | 0.730 |
Why?
| | Kidney Failure, Chronic | 10 | 2021 | 490 | 0.600 |
Why?
| | Proportional Hazards Models | 18 | 2023 | 1076 | 0.470 |
Why?
| | Cause of Death | 8 | 2018 | 360 | 0.420 |
Why?
| | Acute Kidney Injury | 6 | 2023 | 676 | 0.390 |
Why?
| | Middle Aged | 50 | 2021 | 26552 | 0.370 |
Why?
| | Waiting Lists | 4 | 2023 | 204 | 0.370 |
Why?
| | Aged | 44 | 2020 | 18944 | 0.370 |
Why?
| | Living Donors | 6 | 2023 | 270 | 0.370 |
Why?
| | Body Mass Index | 7 | 2020 | 1952 | 0.360 |
Why?
| | Male | 70 | 2021 | 55112 | 0.350 |
Why?
| | Female | 69 | 2022 | 59115 | 0.340 |
Why?
| | Health Expenditures | 2 | 2022 | 172 | 0.330 |
Why?
| | Tissue Donors | 3 | 2021 | 313 | 0.330 |
Why?
| | Aged, 80 and over | 22 | 2019 | 6296 | 0.320 |
Why?
| | Electronic Health Records | 7 | 2017 | 801 | 0.290 |
Why?
| | Ohio | 10 | 2017 | 134 | 0.290 |
Why?
| | Renal Dialysis | 7 | 2018 | 377 | 0.290 |
Why?
| | Kidney Diseases | 4 | 2011 | 348 | 0.280 |
Why?
| | Risk Factors | 24 | 2023 | 8606 | 0.280 |
Why?
| | Humans | 80 | 2023 | 113531 | 0.280 |
Why?
| | Kaplan-Meier Estimate | 10 | 2021 | 809 | 0.270 |
Why?
| | Retrospective Studies | 27 | 2023 | 12504 | 0.250 |
Why?
| | Kidney | 7 | 2021 | 1179 | 0.250 |
Why?
| | Patient Navigation | 2 | 2017 | 63 | 0.240 |
Why?
| | Follow-Up Studies | 13 | 2020 | 4384 | 0.230 |
Why?
| | United States | 18 | 2022 | 12137 | 0.230 |
Why?
| | Graft Survival | 3 | 2021 | 441 | 0.220 |
Why?
| | Body Height | 1 | 2005 | 180 | 0.220 |
Why?
| | Knee Injuries | 1 | 2005 | 88 | 0.220 |
Why?
| | Health Services Accessibility | 3 | 2020 | 756 | 0.220 |
Why?
| | Transplant Recipients | 3 | 2021 | 130 | 0.220 |
Why?
| | Nephrology | 2 | 2021 | 48 | 0.210 |
Why?
| | Obesity | 5 | 2016 | 2501 | 0.210 |
Why?
| | Nephrologists | 1 | 2023 | 13 | 0.210 |
Why?
| | Time Factors | 14 | 2021 | 6032 | 0.210 |
Why?
| | Travel | 2 | 2020 | 117 | 0.210 |
Why?
| | Anterior Cruciate Ligament Injuries | 1 | 2005 | 130 | 0.210 |
Why?
| | Donor Selection | 2 | 2021 | 65 | 0.200 |
Why?
| | Risk Assessment | 11 | 2021 | 2953 | 0.200 |
Why?
| | Nutrition Surveys | 4 | 2021 | 225 | 0.200 |
Why?
| | Adult | 27 | 2023 | 30245 | 0.200 |
Why?
| | Disease Progression | 9 | 2021 | 2364 | 0.190 |
Why?
| | Stomach Diseases | 1 | 2021 | 19 | 0.190 |
Why?
| | Insulin Resistance | 3 | 2020 | 1068 | 0.190 |
Why?
| | Severity of Illness Index | 8 | 2019 | 2530 | 0.180 |
Why?
| | Histamine H2 Antagonists | 1 | 2021 | 26 | 0.180 |
Why?
| | Comorbidity | 8 | 2021 | 1443 | 0.180 |
Why?
| | Transplants | 1 | 2021 | 36 | 0.180 |
Why?
| | Proteinuria | 1 | 2021 | 77 | 0.180 |
Why?
| | Age Factors | 9 | 2021 | 2875 | 0.180 |
Why?
| | Body Weight | 1 | 2005 | 853 | 0.180 |
Why?
| | Hypertension | 5 | 2017 | 1051 | 0.180 |
Why?
| | Proton Pump Inhibitors | 1 | 2021 | 94 | 0.170 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2023 | 238 | 0.170 |
Why?
| | Ventricular Function, Left | 3 | 2019 | 469 | 0.170 |
Why?
| | Abdominal Fat | 1 | 2020 | 39 | 0.170 |
Why?
| | Nephrectomy | 1 | 2021 | 149 | 0.170 |
Why?
| | Cohort Studies | 11 | 2020 | 4880 | 0.170 |
Why?
| | Heart Transplantation | 2 | 2021 | 652 | 0.170 |
Why?
| | Chi-Square Distribution | 7 | 2016 | 493 | 0.160 |
Why?
| | Magnesium | 1 | 2020 | 144 | 0.160 |
Why?
| | Career Choice | 1 | 2021 | 177 | 0.160 |
Why?
| | Internal Medicine | 1 | 2021 | 211 | 0.160 |
Why?
| | Mortality | 2 | 2018 | 282 | 0.160 |
Why?
| | Treatment Outcome | 14 | 2021 | 9006 | 0.160 |
Why?
| | Propensity Score | 5 | 2020 | 225 | 0.160 |
Why?
| | Stroke Volume | 2 | 2019 | 510 | 0.160 |
Why?
| | Terminology as Topic | 1 | 2019 | 185 | 0.150 |
Why?
| | Graft Rejection | 4 | 2021 | 508 | 0.150 |
Why?
| | Immunologic Factors | 1 | 2020 | 211 | 0.150 |
Why?
| | Resource Allocation | 1 | 2018 | 37 | 0.150 |
Why?
| | Program Evaluation | 2 | 2021 | 821 | 0.150 |
Why?
| | Medicaid | 1 | 2022 | 404 | 0.150 |
Why?
| | Gout Suppressants | 1 | 2017 | 20 | 0.140 |
Why?
| | Hypernatremia | 1 | 2017 | 7 | 0.140 |
Why?
| | Hyperuricemia | 1 | 2017 | 43 | 0.140 |
Why?
| | Health Records, Personal | 1 | 2017 | 24 | 0.140 |
Why?
| | Heart Valve Prosthesis | 1 | 2019 | 121 | 0.140 |
Why?
| | Cholesterol, HDL | 1 | 2018 | 184 | 0.140 |
Why?
| | Sex Factors | 5 | 2021 | 1705 | 0.140 |
Why?
| | Cardiac Surgical Procedures | 3 | 2007 | 408 | 0.140 |
Why?
| | Hyponatremia | 1 | 2017 | 37 | 0.140 |
Why?
| | Health Care Costs | 1 | 2020 | 381 | 0.140 |
Why?
| | Incidence | 6 | 2021 | 2310 | 0.140 |
Why?
| | Logistic Models | 7 | 2015 | 1832 | 0.140 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2019 | 152 | 0.130 |
Why?
| | Uric Acid | 1 | 2017 | 148 | 0.130 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2020 | 283 | 0.130 |
Why?
| | Diabetic Nephropathies | 2 | 2017 | 234 | 0.130 |
Why?
| | Creatinine | 3 | 2023 | 434 | 0.130 |
Why?
| | Contrast Media | 1 | 2018 | 346 | 0.130 |
Why?
| | Vascular Resistance | 2 | 2015 | 337 | 0.130 |
Why?
| | Hypokalemia | 1 | 2015 | 23 | 0.120 |
Why?
| | Diet, Reducing | 1 | 2015 | 75 | 0.120 |
Why?
| | Aortic Valve Stenosis | 1 | 2019 | 266 | 0.120 |
Why?
| | Blood Pressure | 3 | 2017 | 1521 | 0.120 |
Why?
| | Hyperkalemia | 1 | 2015 | 26 | 0.120 |
Why?
| | Multivariate Analysis | 7 | 2016 | 1421 | 0.120 |
Why?
| | Program Development | 2 | 2015 | 338 | 0.120 |
Why?
| | Catheters | 1 | 2015 | 63 | 0.120 |
Why?
| | Patient Selection | 1 | 2018 | 625 | 0.120 |
Why?
| | Electric Countershock | 1 | 2015 | 104 | 0.120 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2017 | 229 | 0.120 |
Why?
| | Adipokines | 1 | 2014 | 42 | 0.120 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 679 | 0.120 |
Why?
| | Atrial Fibrillation | 1 | 2018 | 325 | 0.120 |
Why?
| | Patient Education as Topic | 2 | 2017 | 665 | 0.110 |
Why?
| | Chelating Agents | 1 | 2014 | 60 | 0.110 |
Why?
| | Death, Sudden, Cardiac | 1 | 2015 | 160 | 0.110 |
Why?
| | Primary Prevention | 1 | 2015 | 171 | 0.110 |
Why?
| | Odds Ratio | 4 | 2014 | 953 | 0.110 |
Why?
| | Phosphates | 1 | 2014 | 154 | 0.110 |
Why?
| | Lung Diseases | 1 | 2019 | 688 | 0.110 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2016 | 902 | 0.110 |
Why?
| | Arrhythmias, Cardiac | 1 | 2015 | 281 | 0.100 |
Why?
| | Alkaline Phosphatase | 1 | 2013 | 141 | 0.100 |
Why?
| | Bronchiolitis Obliterans | 2 | 2010 | 66 | 0.100 |
Why?
| | Ultrasonography, Doppler, Duplex | 1 | 2012 | 39 | 0.100 |
Why?
| | Prognosis | 6 | 2018 | 3318 | 0.100 |
Why?
| | Bariatric Surgery | 1 | 2014 | 159 | 0.100 |
Why?
| | Internship and Residency | 1 | 2021 | 920 | 0.100 |
Why?
| | Defibrillators, Implantable | 1 | 2015 | 288 | 0.100 |
Why?
| | Hypoglycemic Agents | 2 | 2010 | 1006 | 0.100 |
Why?
| | Exercise Therapy | 1 | 2015 | 351 | 0.100 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2015 | 361 | 0.100 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2010 | 2088 | 0.100 |
Why?
| | Carotid Stenosis | 1 | 2012 | 79 | 0.090 |
Why?
| | Follicular Fluid | 1 | 2011 | 5 | 0.090 |
Why?
| | Sperm Injections, Intracytoplasmic | 1 | 2011 | 7 | 0.090 |
Why?
| | Bicarbonates | 1 | 2011 | 41 | 0.090 |
Why?
| | Sunscreening Agents | 1 | 2011 | 17 | 0.090 |
Why?
| | Coronary Disease | 2 | 2016 | 347 | 0.090 |
Why?
| | Survival Rate | 4 | 2019 | 1634 | 0.090 |
Why?
| | Stents | 2 | 2012 | 463 | 0.090 |
Why?
| | Motivation | 1 | 2015 | 486 | 0.090 |
Why?
| | Infertility | 1 | 2011 | 45 | 0.090 |
Why?
| | Testosterone | 1 | 2014 | 341 | 0.090 |
Why?
| | Blood Flow Velocity | 1 | 2012 | 374 | 0.090 |
Why?
| | Adipose Tissue | 1 | 2014 | 537 | 0.090 |
Why?
| | Inflammation | 1 | 2020 | 2444 | 0.090 |
Why?
| | Young Adult | 7 | 2021 | 10400 | 0.090 |
Why?
| | Triglycerides | 1 | 2012 | 464 | 0.080 |
Why?
| | Chronic Disease | 6 | 2011 | 1570 | 0.080 |
Why?
| | Hepatitis, Autoimmune | 1 | 2010 | 27 | 0.080 |
Why?
| | Motor Activity | 1 | 2014 | 623 | 0.080 |
Why?
| | Metabolic Syndrome | 1 | 2013 | 317 | 0.080 |
Why?
| | Cytomegalovirus Infections | 2 | 2009 | 175 | 0.080 |
Why?
| | Health Surveys | 1 | 2011 | 440 | 0.080 |
Why?
| | Vitamin D Deficiency | 1 | 2011 | 158 | 0.080 |
Why?
| | Quality of Health Care | 1 | 2014 | 572 | 0.080 |
Why?
| | Reactive Oxygen Species | 1 | 2011 | 516 | 0.080 |
Why?
| | Asthma | 1 | 2021 | 2016 | 0.080 |
Why?
| | Orthotic Devices | 1 | 2008 | 28 | 0.080 |
Why?
| | Elasticity | 1 | 2009 | 187 | 0.080 |
Why?
| | Insurance, Health | 2 | 2022 | 243 | 0.080 |
Why?
| | Vitamin D | 1 | 2011 | 339 | 0.070 |
Why?
| | Liver Cirrhosis | 1 | 2010 | 226 | 0.070 |
Why?
| | Splenorenal Shunt, Surgical | 1 | 2007 | 3 | 0.070 |
Why?
| | Practice Patterns, Physicians' | 2 | 2014 | 1176 | 0.070 |
Why?
| | Gait Disorders, Neurologic | 1 | 2008 | 40 | 0.070 |
Why?
| | Brachial Artery | 1 | 2009 | 173 | 0.070 |
Why?
| | Cytomegalovirus | 2 | 2009 | 140 | 0.070 |
Why?
| | Mycoses | 1 | 2008 | 66 | 0.070 |
Why?
| | Esophageal and Gastric Varices | 1 | 2007 | 30 | 0.070 |
Why?
| | Veterans | 1 | 2018 | 1248 | 0.070 |
Why?
| | Hip Joint | 1 | 2008 | 124 | 0.070 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2007 | 36 | 0.070 |
Why?
| | Attitude of Health Personnel | 2 | 2021 | 970 | 0.070 |
Why?
| | Diabetic Angiopathies | 1 | 2009 | 246 | 0.070 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2007 | 100 | 0.070 |
Why?
| | Medical Staff | 1 | 2006 | 16 | 0.070 |
Why?
| | Prospective Studies | 5 | 2022 | 6189 | 0.070 |
Why?
| | Staff Development | 1 | 2006 | 39 | 0.070 |
Why?
| | Heart Failure | 4 | 2016 | 1955 | 0.070 |
Why?
| | Adolescent | 8 | 2021 | 17724 | 0.060 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 2006 | 43 | 0.060 |
Why?
| | Diskectomy | 1 | 2005 | 14 | 0.060 |
Why?
| | Survival Analysis | 4 | 2010 | 1203 | 0.060 |
Why?
| | Splanchnic Circulation | 1 | 2005 | 10 | 0.060 |
Why?
| | Complementary Therapies | 1 | 2006 | 74 | 0.060 |
Why?
| | Problem-Based Learning | 1 | 2006 | 75 | 0.060 |
Why?
| | Mesenteric Artery, Superior | 1 | 2005 | 13 | 0.060 |
Why?
| | Health Status | 2 | 2021 | 716 | 0.060 |
Why?
| | Intervertebral Disc | 1 | 2005 | 36 | 0.060 |
Why?
| | Intervertebral Disc Displacement | 1 | 2005 | 37 | 0.060 |
Why?
| | Tissue and Organ Procurement | 2 | 2018 | 223 | 0.060 |
Why?
| | Oxidative Stress | 1 | 2011 | 1065 | 0.060 |
Why?
| | Education, Medical, Continuing | 1 | 2006 | 115 | 0.060 |
Why?
| | Astrocytoma | 1 | 2006 | 106 | 0.060 |
Why?
| | Hyperthermia, Induced | 1 | 2005 | 66 | 0.060 |
Why?
| | Ileostomy | 1 | 2005 | 18 | 0.060 |
Why?
| | Proctocolectomy, Restorative | 1 | 2005 | 19 | 0.060 |
Why?
| | Poisson Distribution | 1 | 2005 | 71 | 0.060 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2005 | 102 | 0.060 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2017 | 1168 | 0.060 |
Why?
| | Low Back Pain | 1 | 2005 | 93 | 0.060 |
Why?
| | Anterior Cruciate Ligament | 1 | 2005 | 79 | 0.060 |
Why?
| | Lung | 1 | 2016 | 3497 | 0.060 |
Why?
| | Models, Biological | 1 | 2010 | 1589 | 0.060 |
Why?
| | Cardiology | 1 | 2006 | 260 | 0.050 |
Why?
| | Multiple Sclerosis | 1 | 2008 | 363 | 0.050 |
Why?
| | Analysis of Variance | 2 | 2020 | 1208 | 0.050 |
Why?
| | Waist Circumference | 2 | 2014 | 120 | 0.050 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1733 | 0.050 |
Why?
| | Pneumonia | 1 | 2008 | 561 | 0.050 |
Why?
| | Urinalysis | 1 | 2023 | 65 | 0.050 |
Why?
| | Ambulatory Care Facilities | 2 | 2017 | 212 | 0.050 |
Why?
| | Catheter Ablation | 1 | 2005 | 288 | 0.050 |
Why?
| | Laboratories | 1 | 2023 | 95 | 0.050 |
Why?
| | Microscopy | 1 | 2023 | 125 | 0.050 |
Why?
| | Biomarkers | 3 | 2020 | 3389 | 0.050 |
Why?
| | Relative Value Scales | 1 | 2021 | 5 | 0.050 |
Why?
| | Work-Life Balance | 1 | 2021 | 10 | 0.050 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 2 | 2015 | 180 | 0.050 |
Why?
| | Contraceptive Agents | 1 | 2022 | 53 | 0.050 |
Why?
| | Diabetes Mellitus | 3 | 2016 | 896 | 0.050 |
Why?
| | ROC Curve | 3 | 2008 | 442 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2020 | 2993 | 0.050 |
Why?
| | Ultrasonography, Doppler | 2 | 2015 | 103 | 0.040 |
Why?
| | Predictive Value of Tests | 3 | 2012 | 1783 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2006 | 1140 | 0.040 |
Why?
| | Vegetables | 1 | 2021 | 133 | 0.040 |
Why?
| | Postoperative Complications | 3 | 2006 | 2120 | 0.040 |
Why?
| | Insurance Coverage | 1 | 2022 | 199 | 0.040 |
Why?
| | Antihypertensive Agents | 2 | 2017 | 427 | 0.040 |
Why?
| | Clinical Clerkship | 1 | 2021 | 72 | 0.040 |
Why?
| | United States Public Health Service | 1 | 2019 | 8 | 0.040 |
Why?
| | Health Services Needs and Demand | 2 | 2015 | 241 | 0.040 |
Why?
| | Mentors | 1 | 2021 | 155 | 0.040 |
Why?
| | Sulfonylurea Compounds | 2 | 2010 | 44 | 0.040 |
Why?
| | Injections, Intra-Arterial | 1 | 2018 | 25 | 0.040 |
Why?
| | Adiposity | 2 | 2014 | 458 | 0.040 |
Why?
| | Child | 6 | 2021 | 18340 | 0.040 |
Why?
| | Cross-Sectional Studies | 3 | 2016 | 4400 | 0.040 |
Why?
| | Injections, Intravenous | 1 | 2018 | 195 | 0.040 |
Why?
| | Brain Neoplasms | 1 | 2006 | 964 | 0.040 |
Why?
| | Linear Models | 1 | 2020 | 767 | 0.040 |
Why?
| | Child, Preschool | 3 | 2021 | 9093 | 0.030 |
Why?
| | Acute Disease | 2 | 2010 | 885 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2017 | 122 | 0.030 |
Why?
| | Coronary Angiography | 1 | 2018 | 307 | 0.030 |
Why?
| | Echocardiography | 1 | 2019 | 563 | 0.030 |
Why?
| | Prevalence | 2 | 2013 | 2244 | 0.030 |
Why?
| | Recovery of Function | 1 | 2019 | 567 | 0.030 |
Why?
| | Survivors | 2 | 2009 | 414 | 0.030 |
Why?
| | Smoking | 2 | 2016 | 1380 | 0.030 |
Why?
| | beta 2-Microglobulin | 1 | 2015 | 44 | 0.030 |
Why?
| | Protective Factors | 1 | 2016 | 86 | 0.030 |
Why?
| | Cystatin C | 1 | 2015 | 62 | 0.030 |
Why?
| | Sensitivity and Specificity | 2 | 2011 | 1682 | 0.030 |
Why?
| | Blood Glucose | 2 | 2015 | 1823 | 0.030 |
Why?
| | Aortic Valve | 1 | 2019 | 391 | 0.030 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2015 | 76 | 0.030 |
Why?
| | Potassium | 1 | 2015 | 127 | 0.030 |
Why?
| | Lumbosacral Region | 1 | 2015 | 45 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2015 | 223 | 0.030 |
Why?
| | Quality Indicators, Health Care | 1 | 2017 | 285 | 0.030 |
Why?
| | United States Department of Veterans Affairs | 1 | 2018 | 561 | 0.030 |
Why?
| | Statistics, Nonparametric | 2 | 2006 | 384 | 0.030 |
Why?
| | Equipment Failure | 1 | 2015 | 106 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2016 | 517 | 0.030 |
Why?
| | Diet | 1 | 2021 | 1076 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2015 | 338 | 0.030 |
Why?
| | Leptin | 1 | 2015 | 207 | 0.030 |
Why?
| | Personnel Selection | 1 | 2015 | 62 | 0.030 |
Why?
| | Drug Utilization Review | 1 | 2014 | 56 | 0.030 |
Why?
| | Exercise Tolerance | 1 | 2015 | 212 | 0.030 |
Why?
| | Adiponectin | 1 | 2015 | 209 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2021 | 4593 | 0.030 |
Why?
| | Phosphorus | 1 | 2014 | 81 | 0.030 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2014 | 64 | 0.030 |
Why?
| | Hypogonadism | 1 | 2014 | 75 | 0.030 |
Why?
| | Prosthesis Design | 1 | 2015 | 282 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 2015 | 360 | 0.030 |
Why?
| | Arterial Pressure | 1 | 2014 | 98 | 0.030 |
Why?
| | Life Style | 1 | 2015 | 427 | 0.030 |
Why?
| | Medicare | 1 | 2018 | 661 | 0.030 |
Why?
| | Glucose Metabolism Disorders | 1 | 2013 | 10 | 0.030 |
Why?
| | Hyperparathyroidism | 1 | 2012 | 12 | 0.030 |
Why?
| | Hypoalbuminemia | 1 | 2012 | 27 | 0.030 |
Why?
| | Arthritis, Rheumatoid | 1 | 2020 | 996 | 0.020 |
Why?
| | Hemoglobins | 1 | 2014 | 303 | 0.020 |
Why?
| | Anthropometry | 1 | 2012 | 182 | 0.020 |
Why?
| | Body Composition | 1 | 2015 | 584 | 0.020 |
Why?
| | Hospitalization | 1 | 2020 | 1765 | 0.020 |
Why?
| | Dyslipidemias | 1 | 2013 | 153 | 0.020 |
Why?
| | Length of Stay | 2 | 2006 | 963 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2021 | 1815 | 0.020 |
Why?
| | Glipizide | 1 | 2010 | 6 | 0.020 |
Why?
| | Glyburide | 1 | 2010 | 34 | 0.020 |
Why?
| | Regression Analysis | 1 | 2012 | 932 | 0.020 |
Why?
| | Healthcare Disparities | 1 | 2015 | 479 | 0.020 |
Why?
| | Heart-Lung Transplantation | 1 | 2009 | 9 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 2269 | 0.020 |
Why?
| | Lipids | 1 | 2013 | 558 | 0.020 |
Why?
| | Educational Status | 1 | 2011 | 404 | 0.020 |
Why?
| | Seasons | 1 | 2011 | 437 | 0.020 |
Why?
| | Cyclosporine | 1 | 2009 | 160 | 0.020 |
Why?
| | Calcium | 1 | 2014 | 1086 | 0.020 |
Why?
| | Europe | 1 | 2009 | 331 | 0.020 |
Why?
| | North America | 1 | 2009 | 256 | 0.020 |
Why?
| | Tacrolimus | 1 | 2009 | 133 | 0.020 |
Why?
| | Thiazolidinediones | 1 | 2009 | 134 | 0.020 |
Why?
| | Kidney Function Tests | 1 | 2008 | 139 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2014 | 2361 | 0.020 |
Why?
| | Antioxidants | 1 | 2011 | 527 | 0.020 |
Why?
| | Primary Health Care | 1 | 2017 | 1502 | 0.020 |
Why?
| | Coronary Artery Bypass | 1 | 2009 | 196 | 0.020 |
Why?
| | Reference Values | 1 | 2009 | 735 | 0.020 |
Why?
| | Quality-Adjusted Life Years | 1 | 2007 | 103 | 0.020 |
Why?
| | Dialysis | 1 | 2006 | 18 | 0.020 |
Why?
| | Salvage Therapy | 1 | 2007 | 125 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2018 | 1725 | 0.020 |
Why?
| | Negativism | 1 | 2006 | 4 | 0.020 |
Why?
| | Equipment Design | 1 | 2008 | 496 | 0.020 |
Why?
| | Religion and Psychology | 1 | 2006 | 24 | 0.020 |
Why?
| | Secondary Prevention | 1 | 2007 | 220 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 2008 | 348 | 0.020 |
Why?
| | HL-60 Cells | 1 | 2006 | 28 | 0.020 |
Why?
| | Cerebrovascular Disorders | 1 | 2006 | 82 | 0.020 |
Why?
| | Peripheral Vascular Diseases | 1 | 2006 | 97 | 0.020 |
Why?
| | Muscle Strength | 1 | 2008 | 270 | 0.020 |
Why?
| | Gait | 1 | 2008 | 250 | 0.020 |
Why?
| | Morbidity | 1 | 2006 | 275 | 0.020 |
Why?
| | Activities of Daily Living | 1 | 2008 | 348 | 0.020 |
Why?
| | Metformin | 1 | 2009 | 273 | 0.020 |
Why?
| | Immunosuppressive Agents | 1 | 2009 | 633 | 0.020 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2005 | 27 | 0.020 |
Why?
| | Surgical Stapling | 1 | 2005 | 9 | 0.020 |
Why?
| | Cardiopulmonary Bypass | 1 | 2006 | 173 | 0.020 |
Why?
| | Quality of Life | 1 | 2015 | 2335 | 0.010 |
Why?
| | Cost-Benefit Analysis | 1 | 2007 | 542 | 0.010 |
Why?
| | Patient Satisfaction | 1 | 2008 | 570 | 0.010 |
Why?
| | Neoplasms | 1 | 2018 | 2082 | 0.010 |
Why?
| | Anastomosis, Surgical | 1 | 2005 | 131 | 0.010 |
Why?
| | Teaching | 1 | 2006 | 197 | 0.010 |
Why?
| | Suture Techniques | 1 | 2005 | 114 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2006 | 834 | 0.010 |
Why?
| | Perioperative Care | 1 | 2005 | 127 | 0.010 |
Why?
| | Histological Techniques | 1 | 2004 | 40 | 0.010 |
Why?
| | Delivery of Health Care | 1 | 2010 | 828 | 0.010 |
Why?
| | Pain Measurement | 1 | 2005 | 440 | 0.010 |
Why?
| | Viremia | 1 | 2004 | 122 | 0.010 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2005 | 175 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2006 | 780 | 0.010 |
Why?
| | Viral Load | 1 | 2004 | 403 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 2006 | 662 | 0.010 |
Why?
| | Pilot Projects | 1 | 2006 | 1356 | 0.010 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2004 | 578 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2004 | 1604 | 0.010 |
Why?
| | Myocardial Infarction | 1 | 2006 | 932 | 0.010 |
Why?
| | Pregnancy | 1 | 2011 | 5490 | 0.010 |
Why?
| | Pneumonia, Viral | 1 | 2004 | 333 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2006 | 2507 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2006 | 3802 | 0.010 |
Why?
| | Infant | 1 | 2010 | 7922 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2005 | 5032 | 0.010 |
Why?
| | Brain | 1 | 2006 | 2309 | 0.010 |
Why?
|
|
Arrigain's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|